Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Sunitinib

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCURO1653

    03/02/2017

    A Phase 3, Multinational, Randomized, Open-Label, Parallel-Arm Study of AVELUMAB (MSB0010718C) in Combination with AXITINIB (INLYTA?) versus SUNITINIB (SUTENT?) Monotherapy in the First-Line Treatment of Patients with Advanced Renal Cell Carcinoma

    Treatment

    ECOGEAY131-M

    07/16/2015

    Molecular Analysis for Therapy Choice


    Print this page for your doctor